MARINA DEL REY, Calif., July 21, 2011 (GLOBE NEWSWIRE) -- Atlas Therapeutics Corporation (OTCBB:ATTH), the manufacturer of the innovative myostatin inhibitor, MYO-T12(R), has announced that Dr. Louis Aronne, a leading authority in the field of obesity research and treatment, has joined the Company's board of directors.
